Press Releases Latest May 02, 2024 Theratechnologies to Present Long-Term Efficacy, Safety and Pharmacokinetic Data on Use of TH1902 (sudocetaxel zendusortide) in Solid Tumors at 2024 ASCO Meeting Press Releases Year None202420232022202120202019201820172016201520142013 Sep 04, 2013 Theratechnologies Provides Manufacturing Update on EGRIFTA Jul 17, 2013 Securities Class Action Update Jul 11, 2013 Theratechnologies obtains US Patent for Improving Cognitive Function with Tesamorelin in Patients Suffering from MCI Jul 10, 2013 Theratechnologies Announces Financial Results for Second Quarter of 2013 Jul 08, 2013 Request for Reconsideration in Canada: Meeting With Scientific Advisory Committee Authorized Jul 03, 2013 Theratechnologies to Announce Second Quarter 2013 Financial Results Jun 28, 2013 Theratechnologies provides regulatory update for Colombia May 27, 2013 Information on Class Action Motion May 24, 2013 Announcements in Conjunction With Theratechnologies Annual Meeting Apr 11, 2013 Theratechnologies Announces Financial Results for First Quarter of 2013 First page « Previous page ‹ … Page 29 Page 30 Page 31 Page 32 Page 33 Page 34 Current page 35 Page 36 Page 37 Next page › Last page » Displaying 341 - 350 of 361
May 02, 2024 Theratechnologies to Present Long-Term Efficacy, Safety and Pharmacokinetic Data on Use of TH1902 (sudocetaxel zendusortide) in Solid Tumors at 2024 ASCO Meeting
Jul 11, 2013 Theratechnologies obtains US Patent for Improving Cognitive Function with Tesamorelin in Patients Suffering from MCI
Jul 08, 2013 Request for Reconsideration in Canada: Meeting With Scientific Advisory Committee Authorized